Shepherd Kaplan Krochuk’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-7,356
Closed -$343K 225
2018
Q3
$343K Hold
7,356
0.18% 137
2018
Q2
$318K Hold
7,356
0.19% 137
2018
Q1
$409K Hold
7,356
0.25% 116
2017
Q4
$393K Hold
7,356
0.24% 118
2017
Q3
$317K Hold
7,356
0.26% 110
2017
Q2
$444K Hold
7,356
0.26% 88
2017
Q1
$510K Hold
7,356
0.26% 76
2016
Q4
$490K Sell
7,356
-1,889
-20% -$123K 0.14% 86
2016
Q3
$612K Sell
9,245
-507
-5% -$34.7K 0.13% 104
2016
Q2
$706K Hold
9,752
0.18% 76
2016
Q1
$630K Buy
9,752
+112
+1% +$7.43K 0.2% 81
2015
Q4
$691K Buy
9,640
+380
+4% +$28.1K 0.18% 83
2015
Q3
$711K Hold
9,260
0.19% 81
2015
Q2
$686K Hold
9,260
0.13% 133
2015
Q1
$671K Hold
9,260
0.12% 137
2014
Q4
$612K Hold
9,260
0.1% 188
2014
Q3
$508K Hold
9,260
0.07% 209
2014
Q2
$538K Sell
9,260
-2,082
-18% -$123K 0.06% 211
2014
Q1
$703K Hold
11,342
0.08% 172
2013
Q4
$605K Hold
11,342
0.08% 183
2013
Q3
$569K Hold
11,342
0.09% 189
2013
Q2
$519K Buy
+11,342
New +$508K 0.1% 190

Other funds holding MD

Shepherd Kaplan Krochuk's MD Position: Q4 2018 in Review

Shepherd Kaplan Krochuk sold out of Pediatrix Medical (MD) in Q4 2018, closing a stake of 7,356 shares — an estimated $343K sold.

Shepherd Kaplan Krochuk first reported a position in MD in Q2 2013 and held it in 22 quarters. The position peaked at $711K in Q3 2015. 307 funds tracked by Wall St. Rank hold MD as of Q4 2018.

  • Shepherd Kaplan Krochuk reported no remaining Pediatrix Medical position as of Q4 2018 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 7,356 Pediatrix Medical shares in Q4 2018, an estimated $343K.
  • Shepherd Kaplan Krochuk first reported a position in Pediatrix Medical in Q2 2013 and held it in 22 quarters.
  • Shepherd Kaplan Krochuk's Pediatrix Medical position peaked at $711K in Q3 2015.
  • 307 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2018.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2018, filed 12 Feb 2019.